|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang X, Xiao D, Wang Z, Zou Y, Huang L,
Lin W, Deng Q, Pan H, Zhou J, Liang C, et al: MicroRNA-26a/b
regulate DNA replication licensing, tumorigenesis, and prognosis by
targeting CDC6 in lung cancer. Mol Cancer Res. 12:1535–1546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hall RD, Le TM, Haggstrom DE and Gentzler
RD: Angiogenesis inhibition as a therapeutic strategy in non-small
cell lung cancer (NSCLC). Transl Lung Cancer Res. 4:515–523.
2015.PubMed/NCBI
|
|
4
|
Liu MX, Zhou KC and Cao Y: MCRS1
overexpression, which is specifically inhibited by miR-129*,
promotes the epithelial-mesenchymal transition and metastasis in
non-small cell lung cancer. Mol Cancer. 13:2452014. View Article : Google Scholar
|
|
5
|
Manraj K and Saurabh M: Chronic pain grade
questionnaire. J Physiother. 59:602013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luanpitpong S, Li J, Manke A, Brundage K,
Ellis E, McLaughlin SL, Angsutararux P, Chanthra N, Voronkova M,
Chen YC, et al: SLUG is required for SOX9 stabilization and
functions to promote cancer stem cells and metastasis in human lung
carcinoma. Oncogene. Sep 21–2015.Epub ahead of print. PubMed/NCBI
|
|
7
|
Jin Y, Li F, Zheng C, Wang Y, Fang Z, Guo
C, Wang X, Liu H, Deng L, Li C, Wang H, et al: NEDD9 promotes lung
cancer metastasis through epithelial-mesenchymal transition. Int J
Cancer. 134:2294–2304. 2014. View Article : Google Scholar
|
|
8
|
Nurden AT, Fiore M, Nurden P and Pillois
X: Glanzmann thrombasthenia: A review of ITGA2B and ITGB3 defects
with emphasis on variants, phenotypic variability, and mouse
models. Blood. 118:5996–6005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller PG, Al-Shahrour F, Hartwell KA, Chu
LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey
ME, et al: In Vivo RNAi screening identifies a leukemia-specific
dependence on integrin beta 3 signaling. Cancer Cell. 24:45–58.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lei Y, Huang K, Gao C, Lau QC, Pan H, Xie
K, Li J, Liu R, Zhang T, Xie N, et al: Proteomics identification of
ITGB3 as a key regulator in reactive oxygen species-induced
migration and invasion of colorectal cancer cells. Mol Cell
Proteomics: MCP. 10:M110 0053972011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Sahaf O, Wang JH, Browne TJ, Cotter TG
and Redmond HP: Surgical injury enhances the expression of genes
that mediate breast cancer metastasis to the lung. Ann Surg.
252:1037–1043. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao B, Han H, Chen J, Zhang Z, Li S, Fang
F, Zheng Q, Ma Y, Zhang J, Wu N, et al: MicroRNA let-7c inhibits
migration and invasion of human non-small cell lung cancer by
targeting ITGB3 and MAP4K3. Cancer Lett. 342:43–51. 2014.
View Article : Google Scholar
|
|
13
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lei L, Huang Y and Gong W: Inhibition of
miR-92b suppresses nonsmall cell lung cancer cells growth and
motility by targeting RECK. Mol Cell Biochem. 387:171–176. 2014.
View Article : Google Scholar
|
|
15
|
Xu T, Liu X, Han L, Shen H, Liu L and Shu
Y: Upregulation of miR-9 expression as a poor prognostic biomarker
in patients with non-small cell lung cancer. Clin Transl Oncol.
16:469–475. 2014. View Article : Google Scholar
|
|
16
|
Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan
M, Jeon YJ, Li B, Vicentini C, Peng Y, et al: MicroRNA-224 promotes
tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci
USA. 112:E4288–E4297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu F, Zhang H, Su Y, Kong J, Yu H and Qian
B: Up-regulation of microRNA-183-3p is a potent prognostic marker
for lung adenocarcinoma of female non-smokers. Clin Transl Oncol.
16:980–985. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan F, Shen N, Pang J, Xie D, Deng B,
Molina JR, Yang P and Liu S: Restoration of miR-101 suppresses lung
tumorigenesis through inhibition of DNMT3a-dependent DNA
methylation. Cell Death Dis. 5:e14132014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fujiwara T, Katsuda T, Hagiwara K, Kosaka
N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T,
Ichikawa H, et al: Clinical relevance and therapeutic significance
of microRNA-133a expression profiles and functions in malignant
osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lv M, Xu Y, Tang R, Ren J, Shen S, Chen Y,
Liu B, Hou Y and Wang T: miR141-CXCL1-CXCR2 signaling-induced Treg
recruitment regulates metastases and survival of non-small cell
lung cancer. Mol Cancer Ther. 13:3152–3162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun T, Kalionis B, Lv G, Xia S and Gao W:
Role of exosomal noncoding RNAs in lung carcinogenesis. BioMed Res
Int. 2015:1258072015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barik S: An intronic microRNA silences
genes that are functionally antagonistic to its host gene. Nucleic
Acids Res. 36:5232–5241. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Recht M, Nemes L, Matysiak M,
Manco-Johnson M, Lusher J, Smith M, Mannucci P, Hay C, Abshire T,
O'Brien A, et al: Clinical evaluation of moroctocog alfa (AF-CC), a
new generation of B-domain deleted recombinant factor VIII
(BDDrFVIII) for treatment of haemophilia A: demonstration of
safety, efficacy, and pharmacokinetic equivalence to full-length
recombinant factor VIII. Haemophilia. 15:869–880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang M, Liu R, Sheng J, Liao J, Wang Y,
Pan E, Guo W, Pu Y and Yin L: Differential expression profiles of
microRNAs as potential biomarkers for the early diagnosis of
esophageal squamous cell carcinoma. Oncol Rep. 29:169–176.
2013.
|
|
25
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu H, Zhao L, Fang Q, Sun J, Zhang S, Zhan
C, Liu S and Zhang Y: MiR-338-3p inhibits hepatocarcinoma cells and
sensitizes these cells to sorafenib by targeting hypoxia-induced
factor 1α. PLoS One. 9:e1155652014. View Article : Google Scholar
|
|
27
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and
Li GX: MicroRNA-338-3p inhibits colorectal carcinoma cell invasion
and migration by targeting smoothened. Jpn J Clin Oncol. 44:13–21.
2014. View Article : Google Scholar
|
|
28
|
Funato Y, Terabayashi T, Suenaga N, Seiki
M, Takenawa T and Miki H: IRSp53/Eps8 complex is important for
positive regulation of Rac and cancer cell motility/invasiveness.
Cancer Res. 64:5237–5244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu PS, Jong TH, Maa MC and Leu TH: The
interplay between Eps8 and IRSp53 contributes to Src-mediated
transformation. Oncogene. 29:3977–3989. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Oh SY, Knelson EH, Blobe GC and Mythreye
K: The type III TGFβ receptor regulates filopodia formation via a
Cdc42-mediated IRSp53-N-WASP interaction in epithelial cells.
Biochem J. 454:79–89. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Wit E and van Steensel B: Chromatin
domains in higher eukaryotes: Insights from genome-wide mapping
studies. Chromosoma. 118:25–36. 2009. View Article : Google Scholar
|
|
32
|
Moreno-Hagelsieb G: The power of operon
rearrangements for predicting functional associations. Comput
Struct Biotechnol J. 13:402–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Stephens NA and Sparks LM: Resistance to
the beneficial effects of exercise in type 2 diabetes: Are some
individuals programmed to fail? J Clin Endocrinol Metab. 100:43–52.
2015. View Article : Google Scholar
|
|
35
|
Ling DJ, Chen ZS, Zhang YD, Liao QD, Feng
JX, Zhang XY and Shi TS: MicroRNA-145 inhibits lung cancer cell
metastasis. Mol Med Rep. 11:3108–3114. 2015.
|
|
36
|
Yan S, Liu G, Pei C, Chen W, Li P, Wang Q,
Jin X, Zhu J, Wang M and Liu X: Inhibition of NADPH oxidase
protects against metastasis of human lung cancer by decreasing
microRNA-21. Anticancer Drugs. 26:388–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dou H, Wang Y, Su G and Zhao S: Decreased
plasma let-7c and miR-152 as noninvasive biomarker for
non-small-cell lung cancer. Int J Clin Exp Med. 8:9291–9298.
2015.PubMed/NCBI
|
|
38
|
Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai
Y, Xiao L, Huang S, Chen L, Guo Z, et al: MicroRNA-486 as a
biomarker for early diagnosis and recurrence of non-small cell lung
cancer. PLoS One. 10:e01342202015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhao X, He X, Han X, Yu Y, Ye F, Chen Y,
Hoang T, Xu X, Mi QS, Xin M, et al: MicroRNA-mediated control of
oligodendrocyte differentiation. Neuron. 65:612–626. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Saba R, Goodman CD, Huzarewich RL,
Robertson C and Booth SA: A miRNA signature of prion induced
neurodegeneration. PLoS One. 3:e36522008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ebrahimi-Barough S, Massumi M,
Kouchesfahani HM and Ai J: Derivation of pre-oligodendrocytes from
human endometrial stromal cells by using overexpression of microRNA
338. J Mol Neurosci. 51:337–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ribeiro DM and Sonati MF: Regulation of
human alpha-globin gene expression and alpha-thalassemia. Genet Mol
Res. 7:1045–1053. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tomomura M, Hasegawa Y, Hashikawa T,
Tomomura A, Yuzaki M, Furuichi T and Yano R: Differential
expression and function of apoptosis-associated tyrosine kinase
(AATYK) in the developing mouse brain. Brain Res Mol Brain Res.
112:103–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vellon L, Menendez JA and Lupu R:
AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell
proliferation and survival in breast cancer. Oncogene.
24:3759–3773. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xia ZJ, Hu W, Wang YB, Zhou K and Sun GJ:
Expression heterogeneity research of ITGB3 and BCL-2 in lung
adenocarcinoma tissue and adenocarcinoma cell line. Asian Pac J
Trop Med. 7:473–477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Müller DW and Bosserhoff AK: Integrin beta
3 expression is regulated by let-7a miRNA in malignant melanoma.
Oncogene. 27:6698–6706. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sun L, Liu B, Lin Z, Yao Y, Chen Y, Li Y,
Chen J, Yu D, Tang Z, Wang B, et al: MiR-320a acts as a prognostic
factor and inhibits metastasis of salivary adenoid cystic carcinoma
by targeting ITGB3. Mol Cancer. 14:962015. View Article : Google Scholar : PubMed/NCBI
|
